We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Neuropathix. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
Across 12 Brands
40+ COUNTRY DISTRIBUTION
Health Authority Approval in Mexico and Brazil
$46.9M 2020 REVENUE
Margins Over 75%
6 COMPANIES IN PORTFOLIO
Serving Consumer, B2B, Pharmaceutical Markets
Medical Marijuana, Inc. Reports Net Income of $3.7 Million in 2021 First Quarter Financial and Operational Results
SAN DIEGO, May 25, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medical Marijuana, Inc. (OTC:...
Medical Marijuana, Inc. and Subsidiary Kannaway® Honored as Stevie Award Winners in 2021 American Business Awards
SAN DIEGO, May 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medical Marijuana, Inc. (OTC:...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces April 2021 as the Best Revenue Month in Company History
SAN DIEGO, CA, May 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medical Marijuana, Inc. (OTC:...
The Motley Fool, Yahoo Finance, MG Magazine, and Others Highlight Medical Marijuana, Inc. in Their News Coverage
Medical Marijuana, Inc. and our family of companies made headlines this week for our work bringing...
The development of new cannabinoid products, expanded Medical Marijuana, Inc. operations, CBD...
Medical Marijuana, Inc. Announces Second Quarter Filing Date and Schedules Investor Conference Call for August 15, 2019
SAN DIEGO, Aug. 12, 2019 -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded...
|HIGH||0.0287||52 Week Range||0.01-0.222|
|VOLUME||15119948||Market Cap (real-time)||N/A|
Last Updated: 08-20-2021 (US/Eastern)